Work

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

Year: 2005

Type: article

Source: Urology

DOI: 10.1016/j.urology.2005.04.041

Authors: Bahaa S. Malaeb, Thomas A. Gardner, Vitaly Margulis, Ling Yang, Jay Y. Gillenwater, Leland W.K. Chung, Gail Macik, Kenneth S. Koeneman

Institutions: University of Minnesota, Indiana University Indianapolis, Indiana University, The University of Texas Southwestern Medical Center, University of Virginia Health System, University of Virginia, Emory University, University of Virginia Medical Center

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Congressionally Directed Medical Research Programs

Awards: Targeting Orthotopic and Ossesous Prostate Cancer Xenografts with Selective, Systemic Telomerase Inhibition, Targeting Osteoblastic Bone Metastasis with a Novel Site Restricted Gene Therapy, A Synergy Consortium Targeting the Lethal Phenotypes of Prostate Cancer

OpenAlex ID: W1997389064

FWCI: 0.812

Cites: 25

Cited by: 21

Related to: 10